Information Provided By: 
Fly News Breaks for November 8, 2019
CLXT
Nov 8, 2019 | 08:56 EDT
BMO Capital analyst Kenneth Zaslow lowered his price target on Calyxt to $15 after its Q3 earnings miss, with lower than expected revenue offset in part by the lower operating expenses. The analyst is keeping his Outperform rating on the stock however as he still believes that the company will "transition from proof of concept into established product viability and a fully optimized business model", leveraging its scale and extending its penetration with key customers.
News For CLXT From the Last 2 Days
There are no results for your query CLXT
